133 related articles for article (PubMed ID: 38724214)
1. Borderline tumour recurrence: how quickly does the tumour grow?
Mitchell S; Ramajayan T; Sayasneh A
BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38724214
[TBL] [Abstract][Full Text] [Related]
2. Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa.
Virgilio BA; De Blasis I; Sladkevicius P; Moro F; Zannoni GF; Arciuolo D; Mascilini F; Ciccarone F; Timmerman D; Kaijser J; Fruscio R; Van Holsbeke C; Franchi D; Epstein E; Leone FPG; Guerriero S; Czekierdowski A; Scambia G; Testa AC; Valentin L
Ultrasound Obstet Gynecol; 2019 Dec; 54(6):823-830. PubMed ID: 30937992
[TBL] [Abstract][Full Text] [Related]
3. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
[TBL] [Abstract][Full Text] [Related]
4. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Diagnosis and Management of Recurrent Borderline Ovarian Tumours].
Gauroy E; Larouzée E; Chéreau E; De La Motte Rouge T; Margueritte F; Sallée C; Lacorre A; Gauthier T; Koskas M
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):314-321. PubMed ID: 32004781
[TBL] [Abstract][Full Text] [Related]
5. Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors.
Franchi D; Boveri S; Fruscio R; Fischerova D; Guerriero S; Moruzzi MC; Colombo N; Timmerman D; Valentin L; Testa AC
Ultrasound Obstet Gynecol; 2013 Apr; 41(4):452-8. PubMed ID: 22858859
[TBL] [Abstract][Full Text] [Related]
6. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Epidemiology and Risk Factors of Relapse, Follow-up and Interest of a Completion Surgery].
Margueritte F; Sallee C; Lacorre A; Gauroy E; Larouzee E; Chereau E; De La Motte Rouge T; Koskas M; Gauthier T
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):248-259. PubMed ID: 32004784
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcome and risk factors for recurrence in borderline ovarian tumours.
Yokoyama Y; Moriya T; Takano T; Shoji T; Takahashi O; Nakahara K; Yamada H; Yaegashi N; Okamura K; Izutsu T; Sugiyama T; Tanaka T; Kurachi H; Sato A; Tase T; Mizunuma H
Br J Cancer; 2006 Jun; 94(11):1586-91. PubMed ID: 16685277
[TBL] [Abstract][Full Text] [Related]
8. Fertility sparing treatment of recurrent stage I serous borderline ovarian tumours.
Uzan C; Muller E; Kane A; Gouy S; Bendifallah S; Fauvet R; Darai E; Morice P
Hum Reprod; 2013 Dec; 28(12):3222-6. PubMed ID: 24067602
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative ultrasound through laparoscopic probe in fertility-sparing surgery for borderline ovarian tumor recurrence.
Mascilini F; Quagliozzi L; Bolomini G; Scambia G; Testa AC; Fagotti A
Ultrasound Obstet Gynecol; 2019 Aug; 54(2):280-282. PubMed ID: 30288807
[No Abstract] [Full Text] [Related]
10. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Value of Tumor Markers].
Nyangoh-Timoh K; Bendifallah S; Dion L; Ouldamer L; Levêque J
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):277-286. PubMed ID: 32004789
[TBL] [Abstract][Full Text] [Related]
11. Serous and mucinous borderline ovarian tumours: differences in clinical presentation, high-risk histopathological features, and lethal recurrence rates.
Vasconcelos I; Darb-Esfahani S; Sehouli J
BJOG; 2016 Mar; 123(4):498-508. PubMed ID: 26705090
[TBL] [Abstract][Full Text] [Related]
12. Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors.
Moro F; Baima Poma C; Zannoni GF; Vidal Urbinati A; Pasciuto T; Ludovisi M; Moruzzi MC; Carinelli S; Franchi D; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2017 Dec; 50(6):788-799. PubMed ID: 28101917
[TBL] [Abstract][Full Text] [Related]
13. The presence and location of epithelial implants and implants with epithelial proliferation may predict a higher risk of recurrence in serous borderline ovarian tumors: a clinicopathologic study of 188 cases.
Quddus MR; Sung CJ; Zhang C; Moore RG; Ou JJ; Steinhoff MM; Lawrence WD
Hum Pathol; 2012 May; 43(5):747-52. PubMed ID: 22047646
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature.
Ludovisi M; Foo X; Mainenti S; Testa AC; Arora R; Jurkovic D
J Clin Ultrasound; 2015; 43(9):573-7. PubMed ID: 25706035
[TBL] [Abstract][Full Text] [Related]
15. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
Vasconcelos I; de Sousa Mendes M
Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
[TBL] [Abstract][Full Text] [Related]
16. Late recurrence of pStage 1 low-grade serous ovarian tumor presenting as a symptomatic bone metastasis: a case report.
Kubo C; Nagata S; Fukuda T; Kano R; Tanaka T; Nakanishi K; Ohsawa M; Nakatsuka SI
Diagn Pathol; 2018 Jun; 13(1):43. PubMed ID: 29960592
[TBL] [Abstract][Full Text] [Related]
17. [Borderline Ovarian Tumours: CNGOF Guidelines for Clinical Practice - Imaging].
Abdel Wahab C; Rousset P; Bolze PA; Thomassin-Naggara I
Gynecol Obstet Fertil Senol; 2020 Mar; 48(3):260-276. PubMed ID: 32004779
[TBL] [Abstract][Full Text] [Related]
18. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
19. Serous papillary cystic ovarian borderline tumor: case report.
Idotta R; Scopelliti P; Polimeni C; Lirosi MF
Clin Exp Obstet Gynecol; 2002; 29(4):293-6. PubMed ID: 12635749
[TBL] [Abstract][Full Text] [Related]
20. Sequential recurrences of ovarian granulosa cell tumour 10 and 11 years after initial diagnosis as haemoperitoneum and subhepatic mass: a case report and review of the literature.
Givalos N; Liakakos T; Machairas A; Gakiopoulou H; Karatzas G
Eur J Gynaecol Oncol; 2005; 26(5):572-6. PubMed ID: 16285584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
